Table 4

Change in outcome parameters after 4 weeks of treatment*.

Treatment groups


Parameter

Placebo (n = 45)

Diclofenac (n = 49)

EA (n = 46)

Combined (n = 46)

p-valuea


Number of paracetamol taken (tablets taken per week)

-5.16 (2.33)

-4.43 (1.90)

-7.89 (2.09)

-5.13 (2.06)

NS

50 feet-walk time (sec)

-2.70 (0.52)

-3.52 (0.46)

-4.41 (0.70)

-4.13 (0.54)

NS

VAS

-22.86 (4.02)

-32.99 (3.94)

-48.24 (3.59)

-35.59 (2.74)

<0.05

WOMAC

Pain index

-3.31 (0.68)

-4.90 (0.53)

-5.65 (0.59)

-6.28 (0.77)

<0.05††

Stiffness index

-1.47 (0.31)

-1.55 (0.27)

-2.24 (0.31)

-2.02 (0.28)

NS

Disability index

-12.33 (1.88)

-14.39 (1.77)

-19.17 (2.05)

-18.98 (1.92)

NS

Total score

-17.11 (2.73)

-20.84 (2.43)

-27.07 (2.78)

-27.28 (2.79)

NS

Lequesne's functional index

-3.82 (0.51)

-4.80 (0.61)

-6.44 (0.59)

-5.39 (0.52)

<0.05†††


*Compared values of week 4 versus those of week 0 (run-in peroid), data represent mean (SEM). Statistic analysis: a = one-way ANOVA and Scheffe method. NS= no statistical significance. = EA vs placebo and diclofenac group. †† = combined vs placebo group. ††† = EA vs placebo group.

Sangdee et al. BMC Complementary and Alternative Medicine 2002 2:3   doi:10.1186/1472-6882-2-3

Open Data